FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367320908> ?p ?o ?g. }

• W4367320908 endingPage "e071277" @default.
• W4367320908 startingPage "e071277" @default.
• W4367320908 abstract "Introduction COVID-19 convalescent plasma (CCP) is a possible treatment option for COVID-19. A comprehensive number of clinical trials on CCP efficacy have already been conducted. However, many aspects of CCP treatment still require investigations: in particular (1) Optimisation of the CCP product, (2) Identification of the patient population in need and most likely to benefit from this treatment approach, (3) Timing of administration and (4) CCP efficacy across viral variants in vivo. We aimed to test whether high-titre CCP, administered early, is efficacious in preventing hospitalisation or death in high-risk patients. Methods and analysis COVIC-19 is a multicentre, randomised, open-label, adaptive superiority phase III trial comparing CCP with very high neutralising antibody titre administered within 7 days of symptom onset plus standard of care versus standard of care alone. We will enrol patients in two cohorts of vulnerable patients [(1) elderly 70+ years, or younger with comorbidities; (2) immunocompromised patients]. Up to 1020 participants will be enrolled in each cohort (at least 340 with a sample size re-estimation after reaching 102 patients). The primary endpoint is the proportion of participants with (1) Hospitalisation due to progressive COVID-19, or (2) Who died by day 28 after randomisation. Principal analysis will follow the intention-to-treat principle. Ethics and dissemination Ethical approval has been granted by the University of Ulm ethics committee (#41/22) (lead ethics committee for Germany), Comité de protection des personnes Sud-Est I (CPP Sud-Est I) (#2022-A01307-36) (ethics committee for France), and ErasmusMC ethics committee (#MEC-2022-0365) (ethics committee for the Netherlands). Signed informed consent will be obtained from all included patients. The findings will be published in peer-reviewed journals and presented at relevant stakeholder conferences and meetings. Trial registration Clinical Trials.gov ( NCT05271929 ), EudraCT (2021-006621-22)" @default.
• W4367320908 created "2023-04-29" @default.
• W4367320908 creator A5020843370 @default.
• W4367320908 creator A5024771458 @default.
• W4367320908 creator A5025248485 @default.
• W4367320908 creator A5026174661 @default.
• W4367320908 creator A5034675497 @default.
• W4367320908 creator A5034688119 @default.
• W4367320908 creator A5035886609 @default.
• W4367320908 creator A5036429066 @default.
• W4367320908 creator A5037238243 @default.
• W4367320908 creator A5038511140 @default.
• W4367320908 creator A5039424536 @default.
• W4367320908 creator A5042951039 @default.
• W4367320908 creator A5054325961 @default.
• W4367320908 creator A5062082959 @default.
• W4367320908 creator A5062746447 @default.
• W4367320908 creator A5068469918 @default.
• W4367320908 creator A5076966548 @default.
• W4367320908 creator A5088797832 @default.
• W4367320908 date "2023-04-01" @default.
• W4367320908 modified "2023-09-30" @default.
• W4367320908 title "Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial" @default.
• W4367320908 cites W2020526475 @default.
• W4367320908 cites W2090966916 @default.
• W4367320908 cites W3009035323 @default.
• W4367320908 cites W3032003277 @default.
• W4367320908 cites W3032394272 @default.
• W4367320908 cites W3034339140 @default.
• W4367320908 cites W3034858522 @default.
• W4367320908 cites W3093711492 @default.
• W4367320908 cites W3107586775 @default.
• W4367320908 cites W3110542218 @default.
• W4367320908 cites W3111197543 @default.
• W4367320908 cites W3118278606 @default.
• W4367320908 cites W3119294059 @default.
• W4367320908 cites W3135646190 @default.
• W4367320908 cites W3135856503 @default.
• W4367320908 cites W3160480118 @default.
• W4367320908 cites W3163808478 @default.
• W4367320908 cites W3167220489 @default.
• W4367320908 cites W3167470255 @default.
• W4367320908 cites W3178537193 @default.
• W4367320908 cites W3184640698 @default.
• W4367320908 cites W3188808613 @default.
• W4367320908 cites W3193760974 @default.
• W4367320908 cites W3196996705 @default.
• W4367320908 cites W3197328793 @default.
• W4367320908 cites W3198314694 @default.
• W4367320908 cites W3204742187 @default.
• W4367320908 cites W3216039457 @default.
• W4367320908 cites W4200049484 @default.
• W4367320908 cites W4200321195 @default.
• W4367320908 cites W4205827837 @default.
• W4367320908 cites W4210476768 @default.
• W4367320908 cites W4210673595 @default.
• W4367320908 cites W4220665894 @default.
• W4367320908 cites W4225463324 @default.
• W4367320908 cites W4226144842 @default.
• W4367320908 cites W4226523125 @default.
• W4367320908 cites W4229440329 @default.
• W4367320908 cites W4280553600 @default.
• W4367320908 cites W4280604858 @default.
• W4367320908 cites W4285719527 @default.
• W4367320908 cites W4286433029 @default.
• W4367320908 cites W4289667172 @default.
• W4367320908 cites W4290018558 @default.
• W4367320908 cites W4291690734 @default.
• W4367320908 cites W4292662168 @default.
• W4367320908 cites W4292977643 @default.
• W4367320908 cites W4295046565 @default.
• W4367320908 cites W4295347247 @default.
• W4367320908 cites W4305082410 @default.
• W4367320908 cites W4307813351 @default.
• W4367320908 cites W4308052871 @default.
• W4367320908 cites W4313312703 @default.
• W4367320908 cites W4315753264 @default.
• W4367320908 doi "https://doi.org/10.1136/bmjopen-2022-071277" @default.
• W4367320908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37105693" @default.
• W4367320908 hasPublicationYear "2023" @default.
• W4367320908 type Work @default.
• W4367320908 citedByCount "1" @default.
• W4367320908 countsByYear W43673209082023 @default.
• W4367320908 crossrefType "journal-article" @default.
• W4367320908 hasAuthorship W4367320908A5020843370 @default.
• W4367320908 hasAuthorship W4367320908A5024771458 @default.
• W4367320908 hasAuthorship W4367320908A5025248485 @default.
• W4367320908 hasAuthorship W4367320908A5026174661 @default.
• W4367320908 hasAuthorship W4367320908A5034675497 @default.
• W4367320908 hasAuthorship W4367320908A5034688119 @default.
• W4367320908 hasAuthorship W4367320908A5035886609 @default.
• W4367320908 hasAuthorship W4367320908A5036429066 @default.
• W4367320908 hasAuthorship W4367320908A5037238243 @default.
• W4367320908 hasAuthorship W4367320908A5038511140 @default.
• W4367320908 hasAuthorship W4367320908A5039424536 @default.
• W4367320908 hasAuthorship W4367320908A5042951039 @default.
• W4367320908 hasAuthorship W4367320908A5054325961 @default.
• W4367320908 hasAuthorship W4367320908A5062082959 @default.

• next